The injection is an auto-injector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today ...

Dr. Reddy’s Laboratories announced the launch of Sumatriptan Injection Autoinjector System for Subcutaneous Use, the generic version of GlaxoSmithKline‘s Imitrex STATdose Pen. Sumatriptan is a ...

EWING, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) (“the Company”), a pharmaceutical technology company, announced the first commercialization of the ...

What is sumatriptan used for? Sumatriptan is commonly used for the treatment of migraine with or without aura. An aura may occur before or during a migraine attack, and can include sensory problems ...

Dr Reddy’s Laboratories announced on today that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL, for subcutaneous use in the US market on February 25. It is a therapeutic ...

SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and ...

Please provide your email address to receive an email when new articles are posted on . A low dose of sumatriptan provided significantly higher 2-hour pain freedom and 2-hour pain relief vs. placebo, ...

Sumatriptan Succinate Injection is indicated for 1) the acute treatment of migraine attacks with or without aura and 2) the acute treatment of cluster headache episodes. Sumatriptan Succinate ...

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated February 25, 2014, titled "Dr Reddy's annouces the Lanch of Sumatriptan Injection USP, Autoinjector System" Dr Reddys ...